We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 145

Social media: did you know?
  • Norton Rose Fulbright LLP
  • Global
  • March 20 2014

How many of us actually read social media terms of use? Be wary: you allow public information to be accessible over public search engines. When you

High Court decision thaws copyright protection for data compilations
  • Norton Rose Fulbright LLP
  • Australia
  • June 25 2009

In the landmark copyright case of IceTV Pty Ltd v Nine Network Australia Pty Ltd (2009) 254 ALR 386 (IceTV case), the High Court unanimously held that IceTV did not infringe copyright by reproducing individual items of time and title information from Nine Network’s weekly television schedules

Federal court decision on maintenance fees and equity
  • Norton Rose Fulbright Canada LLP
  • Canada
  • June 19 2008

On June 6, 2008, the Federal Court of Canada released its decision in a case involving payment of maintenance fees, Sarnoff Corporation v. Attorney General of Canada

What’s in a name - or logo, design, shape or packaging?
  • Norton Rose Fulbright Canada LLP
  • Canada
  • July 29 2009

Executives often underestimate the value of their marketing tools when assessing their company’s worth

U.S. Patent and Trademark Office rule changes put on hold
  • Norton Rose Fulbright Canada LLP
  • USA
  • November 9 2007

In August 2007, we reported that the United States Patent and Trademark Office (USPTO) had adopted new rules of practice which, in some instances, would significantly change the way patent applications are prepared, filed, and prosecuted in the U.S

Third party intervention in NOC proceedings will only be allowed in the clearest of cases
  • Norton Rose Fulbright Canada LLP
  • Canada
  • November 2 2007

This is a preliminary decision in Eli Lilly’s appeal of the dismissal of a prohibition proceeding in connection with the drug, ZYPREXA (olanzapine

Court orders statutory compensation for employee inventors
  • Norton Rose Fulbright LLP
  • United Kingdom
  • March 6 2009

Following the recent English High Court decision where two ex-employees were awarded £1.5 million in compensation under the Patents Act for the 'outstanding benefit' that a patent on one of their inventions conferred on their employer, the question is being asked: will this bring a raft of similar claims from employees and ex-employees who feel they have not been fairly rewarded for the financial benefit that their inventions have brought their employers?

Changes to Canadian trade-mark opposition practice in force as of October 1, 2007
  • Norton Rose Fulbright Canada LLP
  • Canada
  • October 10 2007

On October 1, 2007, the Canadian Trade-marks Office implemented changes to the procedures followed by the Trade-marks Opposition Board

Federal Court of Appeal reconfirms that once an NOC issues, a patent holder’s appeal is moot
  • Norton Rose Fulbright Canada LLP
  • Canada
  • November 19 2007

On November 5, 2007, a majority of the Federal Court of Appeal granted a motion brought by Novopharm Limited (“Novopharm”) dismissing an appeal brought by Eli Lilly Canada Inc. (“Eli Lilly”) as moot

Protecting innovation in the oil & gas industry
  • Norton Rose Fulbright Canada LLP
  • Canada
  • February 21 2012

There are various means by which business organizations can protect innovation by preventing unfair use by competitors of the organization’s innovations, while preserving the innovator’s right to use